Baird lowered the firm’s price target on Itron (ITRI) to $129 from $137 and keeps an Outperform rating on the shares. The firm updated its model following strong Q2 results but near-term uncertainty remains.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ITRI:
- Itron Inc. Reports Strong Q2 2025 Financial Results
- Itron’s Strong Financial Performance and Growth Potential: A Buy Rating Despite Short-term Challenges
- JPMorgan upgrades Itron to Overweight, says ‘buy the dip’
- Itron upgraded to Overweight from Neutral at JPMorgan
- Itron reports Q2 EPS $1.62, consensus $1.33